All Stories

  1. Enteral nutrient deprivation in patients leads to a loss of intestinal epithelial barrier function

    Article • Surgery, April 2015, Elsevier

    Dr Kathleen M. Woods Ignatoski

  2. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer

    Article • The Prostate, October 2014, Wiley

    Dr Kathleen M. Woods Ignatoski

  3. Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model

    Article • AJP Gastrointestinal and Liver Physiology, June 2014, American Physiological Society

    Dr Kathleen M. Woods Ignatoski

  4. Distraction-Induced Intestinal Growth: The Role of Mechanotransduction Mechanisms in a Mouse Model of Short Bowel Syndrome

    Article • Tissue Engineering Part A, November 2013, Mary Ann Liebert Inc

    Dr Kathleen M. Woods Ignatoski

  5. Angiotensin Converting Enzyme-Inhibitor Reduces Colitis Severity in an IL-10 Knockout Model

    Article • Digestive Diseases and Sciences, August 2013, Springer Science + Business Media

    Dr Kathleen M. Woods Ignatoski

  6. Abstract 4065: Regulation of luminal breast cancer stem cells by HER2 does not require gene amplification providing a potential molecular explanation for the efficacy of adjuvant trastuzumab in patients with “clinically HER2-negative” breast cancer.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Kathleen M. Woods Ignatoski

  7. HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab

    Article • Cancer Research, February 2013, American Association for Cancer Research (AACR)

    Dr Kathleen M. Woods Ignatoski

  8. Blockade of angiotensin converting enzyme-inhibitor (ACE-I) prevents in immunologically relevant colitis model

    Article • Journal of the American College of Surgeons, September 2012, Elsevier

    Dr Kathleen M. Woods Ignatoski

  9. Worsening Central Sarcopenia and Increasing Intra-Abdominal Fat Correlate with Decreased Survival in Patients with Adrenocortical Carcinoma

    Article • World Journal of Surgery, April 2012, Springer Science + Business Media

    Dr Kathleen M. Woods Ignatoski

  10. Abstract 3470: HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: Implications for efficacy of adjuvant trastuzumab

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Dr Kathleen M. Woods Ignatoski

  11. A quantitative tool to assess degree of sarcopenia objectively in patients with hypercortisolism

    Article • Surgery, December 2011, Elsevier

    Dr Kathleen M. Woods Ignatoski

  12. HER-2 Signaling in Human Breast Cancer

    Article • November 2011, IntechOpen

    Dr Kathleen M. Woods Ignatoski

  13. Directed Trans -Differentiation of Thymus Cells into Parathyroid-Like Cells Without Genetic Manipulation

    Article • Tissue Engineering Part C Methods, November 2011, Mary Ann Liebert Inc

    Dr Kathleen M. Woods Ignatoski

  14. Differentiation of precursors into parathyroid-like cells for treatment of hypoparathyroidism

    Article • Surgery, December 2010, Elsevier

    Dr Kathleen M. Woods Ignatoski

  15. Abstract 5402: Pre-clinical treatment of adrenal cortical carcinoma with a combination of small molecule inhibitors to IGF-1R and mTOR

    Article • Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Dr Kathleen M. Woods Ignatoski

  16. Abstract 482: The HER-2 erbB receptor is vital for growth of breast cancer cells in bone

    Article • Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Dr Kathleen M. Woods Ignatoski

  17. Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression

    Article • American Journal Of Pathology, March 2010, Elsevier

    Dr Kathleen M. Woods Ignatoski

  18. Differentiation of Human Embryonic Stem Cells to a Parathyroid-Like Phenotype

    Article • Stem Cells and Development, September 2009, Mary Ann Liebert Inc

    Dr Kathleen M. Woods Ignatoski

  19. EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling

    Article • The Prostate, April 2009, Wiley

    Dr Kathleen M. Woods Ignatoski

  20. Change in Markers of Bone Metabolism with Chemotherapy for Advanced Prostate Cancer: Interleukin-6 Response Is a Potential Early Indicator of Response to Therapy

    Article • Journal of Interferon & Cytokine Research, February 2009, Mary Ann Liebert Inc

    Dr Kathleen M. Woods Ignatoski

  21. Loss of Raf Kinase Inhibitory Protein Induces Radioresistance in Prostate Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, September 2008, Elsevier

    Dr Kathleen M. Woods Ignatoski

  22. RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model

    Article • The Prostate, June 2008, Wiley

    Dr Kathleen M. Woods Ignatoski

  23. p38MAPK-Activated AKT in HER-2 Overexpressing Human Breast Cancer Cells Acts as an EGF-Independent Survival Signal

    Article • Journal of Surgical Research, September 2007, Elsevier

    Dr Kathleen M. Woods Ignatoski

  24. Why should we still care about oncogenes?

    Article • Molecular Cancer Therapeutics, February 2007, American Association for Cancer Research (AACR)

    Dr Kathleen M. Woods Ignatoski

  25. Molecular Biology: Oncogenes and Tumor Suppressor Genes

    Article • January 2007, Elsevier

    Dr Kathleen M. Woods Ignatoski

  26. New trends in the treatment of bone metastasis

    Article • Journal of Cellular Biochemistry, January 2007, Wiley

    Dr Kathleen M. Woods Ignatoski

  27. Contributors

    Article • January 2007, Elsevier

    Dr Kathleen M. Woods Ignatoski

  28. Cooperative Interactions of HER-2, HPV-16 Oncoproteins in the Malignant Transformation of Human Mammary Epithelial Cells

    Article • Neoplasia, August 2005, Elsevier

    Dr Kathleen M. Woods Ignatoski

  29. p38MAPK Induces Cell Surface α4 Integrin Downregulation to Facilitate erbB-2-Mediated Invasion

    Article • Neoplasia, March 2003, Elsevier

    Dr Kathleen M. Woods Ignatoski

  30. A bcl-xS Adenovirus Selectively Induces Apoptosis in Transformed Cells Compared to Normal Mammary Cells

    Article • Neoplasia, May 2000, Elsevier

    Dr Kathleen M. Woods Ignatoski

  31. erbB-2 Overexpression in Human Mammary Epithelial Cells Confers Growth Factor Independence

    Article • Endocrinology, August 1999, Endocrine Society

    Dr Kathleen M. Woods Ignatoski

  32. erbB-2 Overexpression in Human Mammary Epithelial Cells Confers Growth Factor Independence1

    Article • Endocrinology, August 1999, Endocrine Society

    Dr Kathleen M. Woods Ignatoski

  33. Constitutive activation of pp125fak in newly isolated human breast cancer cell lines

    Article • Breast Cancer Research and Treatment, March 1999, Springer Science + Business Media

    Dr Kathleen M. Woods Ignatoski

  34. Transformation and pp60v-src autophosphorylation correlate with SHC-GRB2 complex formation in rat and chicken cells expressing host-range and kinase-active, transformation-defective alleles of v-src.

    Article • Molecular Biology of the Cell, August 1995, American Society for Cell Biology (ASCB)

    Dr Kathleen M. Woods Ignatoski

  35. Immunoprecipitation and Western Blotting of Phosphotyrosine-Containing Proteins

    Article • Springer Science + Business Media

    Dr Kathleen M. Woods Ignatoski